Anti-inflammatory and antitumor effects of hydroxytyrosol but not oleuropein on experimental glioma in vivo. A putative role for the renin-angiotensin system

Biomedicines

Volumn 6, Issue 1, 2018, Pages

  Ramírez Expósito, María Jesús ^a   Martínez Martos, José Manuel ^a  

^a UNIVERSITY OF JAÉN   (Spain)

Author keywords

Aminopeptidase; C6; Glioma; Hydroxytyrosol; Inflammation; Oleuropein; Renin angiotensin system

Indexed keywords

EID: 85057770134     PISSN: None     EISSN: 22279059     Source Type: Journal    
DOI: 10.3390/biomedicines6010011     Document Type: Article

References (35)

1. Candido, J.; Hagemann, T. Cancer-related inflammation. J. Clin. Immunol. 2013, 33, S79-S84.
2. Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer-related inflammation. Nature 2008, 454, 436-444.
3. Benigni, A.; Cassis, P.; Remuzzi, G. Angiotensin ii revisited: New roles in inflammation, immunology and aging. EMBO Mol. Med. 2010, 2, 247-257.
4. Stegbauer, J.; Coffman, T.M. New insights into angiotensin receptor actions: From blood pressure to aging. Curr. Opin. Nephrol. Hypertens. 2011, 20, 84-88.
5. Wright, J.W.; Harding, J.W. The brain renin-angiotensin system: A diversity of functions and implications for cns diseases. Pflugers Arch. 2013, 465, 133-151.
6. Escobar, E.; Rodriguez-Reyna, T.S.; Arrieta, O.; Sotelo, J. Angiotensin ii, cell proliferation and angiogenesis regulator: Biologic and therapeutic implications in cancer. Curr. Vasc. Pharmacol. 2004, 2, 385-399.
7. Arrieta, O.; Pineda-Olvera, B.; Guevara-Salazar, P.; Hernandez-Pedro, N.; Morales-Espinosa, D.; Ceron-Lizarraga, T.L.; Gonzalez-De la Rosa, C.H.; Rembao, D.; Segura-Pacheco, B.; Sotelo, J. Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis. Br. J. Cancer 2008, 99, 160-166.
8. Juillerat-Jeanneret, L.; Celerier, J.; Chapuis Bernasconi, C.; Nguyen, G.;Wostl, W.; Maerki, H.P.; Janzer, R.C.; Corvol, P.; Gasc, J.M. Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. Br. J. Cancer 2004, 90, 1059-1068.
9. Juillerat-Jeanneret, L.; Lohm, S.; Hamou, M.F.; Pinet, F. Regulation of aminopeptidase a in human brain tumor vasculature: Evidence for a role of transforming growth factor-beta. Lab. Investig. 2000, 80, 973-980.
10. Mayas, M.D.; Ramirez-Exposito, M.J.; Carrera, M.P.; Cobo, M.; Martinez-Martos, J.M. Renin-angiotensin system-regulating aminopeptidases in tumor growth of rat c6 gliomas implanted at the subcutaneous region. Anticancer Res. 2012, 32, 3675-3682.
11. Genest, J.; Cantin, M.; Garcia, R.; Thibault, G.; Gutkowska, J.; Schiffrin, E.; Kuchel, O.; Hamet, P. Extrarenal angiotensin-forming enzymes. Clin. Exp. Hypertens. A 1983, 5, 1065-1080.
12. Johnston, C.I. Ace inhibitors and the kidney. Nephron 1990, 55, 1-2.
13. Ramirez-Exposito, M.J.; Martinez, J.M.; Prieto, I.; Alba, F.; Ramirez, M. Comparative distribution of glutamyl and aspartyl aminopeptidase activities in mouse organs. Horm. Metab. Res. 2000, 32, 161-163.
14. Kambayashi, Y.; Bardhan, S.; Takahashi, K.; Tsuzuki, S.; Inui, H.; Hamakubo, T.; Inagami, T. Molecular cloning of a novel angiotensin ii receptor isoform involved in phosphotyrosine phosphatase inhibition. J. Biol. Chem. 1993, 268, 24543-24546.
15. Mukoyama, M.; Nakajima, M.; Horiuchi, M.; Sasamura, H.; Pratt, R.E.; Dzau, V.J. Expression cloning of type 2 angiotensin ii receptor reveals a unique class of seven-transmembrane receptors. J. Biol. Chem. 1993, 268, 24539-24542.
16. Blair-West, J.R.; Coghlan, J.P.; Denton, D.A.; Funder, J.W.; Scoggins, B.A.; Wright, R.D. The effect of the heptapeptide (2-8) and hexapeptide (3-8) fragments of angiotensin ii on aldosterone secretion. J. Clin. Endocrinol. Metab. 1971, 32, 575-578.
17. Donoghue, M.; Hsieh, F.; Baronas, E.; Godbout, K.; Gosselin, M.; Stagliano, N.; Donovan, M.; Woolf, B.; Robison, K.; Jeyaseelan, R.; et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ace2) converts angiotensin i to angiotensin 1-9. Circ. Res. 2000, 87, E1-E9.
18. Nie,W.; Yan, H.; Li, S.; Zhang, Y.; Yu, F.; Zhu,W.; Fan, F.; Zhu, J. Angiotensin-(1-7) enhances angiotensin ii induced phosphorylation of erk1/2 in mouse bone marrow-derived dendritic cells. Mol. Immunol. 2009, 46, 355-361.
19. Carrera-Gonzalez, M.P.; Ramirez-Exposito, M.J.; Mayas, M.D.; Martinez-Martos, J.M. Protective role of oleuropein and its metabolite hydroxytyrosol on cancer. Trends Food Sci. Technol. 2013, 31, 92-99.
20. Martinez-Martos, J.M.; Mayas, M.D.; Carrera, P.; de Saavedra, J.M.A.; Sanchez-Agesta, R.; Arrazola, M.; Ramirez-Exposito, M.J. Phenolic compounds oleuropein and hydroxytyrosol exert differential effects on glioma development via antioxidant defense systems. J. Funct. Foods 2014, 11, 221-234.
21. Garcia, G.E. Ang ii receptor antagonists as modulators of macrophages polarization. Am. J. Physiol.-Renal Phys. 2010, 298, F868-F869.
22. Santos, R.A.; Ferreira, A.J.; Simoes, E.S.A.C. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-mas axis. Exp. Physiol. 2008, 93, 519-527.
23. Zhao, B.; Ma, Y.; Xu, Z.; Wang, J.; Wang, F.; Wang, D.; Pan, S.; Wu, Y.; Pan, H.; Xu, D.; et al. Hydroxytyrosol, a natural molecule from olive oil, suppresses the growth of human hepatocellular carcinoma cells via inactivating akt and nuclear factor-kappa b pathways. Cancer Lett. 2014, 347, 79-87.
24. Rosignoli, P.; Fuccelli, R.; Sepporta, M.V.; Fabiani, R. In vitro chemo-preventive activities of hydroxytyrosol: The main phenolic compound present in extra-virgin olive oil. Food Funct. 2016, 7, 301-307.
25. Lopez de Las Hazas, M.C.; Pinol, C.; Macia, A.; Motilva, M.J. Hydroxytyrosol and the colonic metabolites derived from virgin olive oil intake induce cell cycle arrest and apoptosis in colon cancer cells. J. Agric. Food Chem. 2017, 65, 6467-6476.
26. Li, S.; Han, Z.; Ma, Y.; Song, R.; Pei, T.; Zheng, T.; Wang, J.; Xu, D.; Fang, X.; Jiang, H.; et al. Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: An in vivo and in vitro study. Oncol. Rep. 2014, 31, 145-152.
27. Fabiani, R. Anti-cancer properties of olive oil secoiridoid phenols: A systematic review of in vivo studies. Food Funct. 2016, 7, 4145-4159.
28. Liu, B.; Liu, Y.; Jiang, Y. Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation by inhibiting angiotensin-(1-7)/mas signaling. Oncol. Rep. 2015, 33, 2583-2591.
29. Manna, C.; D'Angelo, S.; Migliardi, V.; Loffredi, E.; Mazzoni, O.; Morrica, P.; Galletti, P.; Zappia, V. Protective effect of the phenolic fraction from virgin olive oils against oxidative stress in human cells. J. Agric. Food Chem. 2002, 50, 6521-6526.
30. De la Puerta, R.; Martinez Dominguez, M.E.; Ruiz-Gutierrez, V.; Flavill, J.A.; Hoult, J.R. Effects of virgin olive oil phenolics on scavenging of reactive nitrogen species and upon nitrergic neurotransmission. Life Sci. 2001, 69, 1213-1222.
31. Valko, M.; Izakovic, M.; Mazur, M.; Rhodes, C.J.; Telser, J. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem. 2004, 266, 37-56.
32. Hamdi, H.K.; Castellon, R. Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochem. Biophys. Res. Commun. 2005, 334, 769-778.
33. Feng, Z.; Li, X.; Lin, J.; Zheng,W.; Hu, Z.; Xuan, J.; Ni,W.; Pan, X. Oleuropein inhibits the il-1beta-induced expression of inflammatory mediators by suppressing the activation of nf-kappab and mapks in human osteoarthritis chondrocytes. Food Funct. 2017, 8, 3737-3744.
34. Qabaha, K.; Al-Rimawi, F.; Qasem, A.; Naser, S.A. Oleuropein is responsible for the major anti-inflammatory effects of olive leaf extract. J. Med. Food 2017.
35. Kotronoulas, A.; Pizarro, N.; Serra, A.; Robledo, P.; Joglar, J.; Rubio, L.; Hernaez, A.; Tormos, C.; Motilva, M.J.; Fito, M.; et al. Dose-dependent metabolic disposition of hydroxytyrosol and formation of mercapturates in rats. Pharmacol. Res. 2013, 77, 47-56.